Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model (Q34105795)

From Wikidata

Jump to navigation Jump to search

scientific article

Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.

Language	Label	Description	Also known as
English	Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model	scientific article	Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

vector-borne disease

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anders Björklund

1

object named as

Björklund A

1 reference

Europe PubMed Central

31 July 2017

author name string

Kirik D

2

1 reference

Europe PubMed Central

31 July 2017

Rosenblad C

3

1 reference

Europe PubMed Central

31 July 2017

Georgievska B

4

1 reference

Europe PubMed Central

31 July 2017

Lundberg C

5

1 reference

Europe PubMed Central

31 July 2017

Mandel RJ

6

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

886

1 reference

Europe PubMed Central

31 July 2017

1-2

1 reference

Europe PubMed Central

31 July 2017

82-98

1 reference

Europe PubMed Central

31 July 2017

Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Selective and rapid uptake of adeno-associated virus type 2 in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Adenovirus-mediated transgene expression in nonhuman primate brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

The early diagnosis of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Dopaminergic neurons protected from degeneration by GDNF gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced wit lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

PET studies of functional compensation in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Lentiviral vectors: regulated gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Immune responses to adenoviral vectors during gene transfer in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Lentiviral gene transfer to the nonhuman primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Inflammatory responses and their impact on beta-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Stable gene transfer to the nervous system using a non-primate lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

AAV vectors: is clinical success on the horizon?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Adeno-associated virus vectors: activity and applications in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Regulation of gene expression in vivo following transduction by two separate rAAV vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Optimization of the helper-dependent adenovirus system for production and potency in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Lentiviral vectors: turning a deadly foe into a therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Immune responses to adenovirus vectors in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

Development of a self-inactivating lentivirus vector.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902915-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(00)02915-2

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34105795&oldid=1976305467"